Treatment of saphenous vein bypass grafts with ultrasound thrombolysis: A randomized study (ATLAS)

Circulation

Volumn 107, Issue 18, 2003, Pages 2331-2336

  Singh, Mandeep ^a   Rosenschein, Uri ^b   Ho, Kalon K L ^c   Berger, Peter B ^a   Kuntz, Richard ^d   Holmes Jr , David R ^a  

^a MAYO CLINIC   (United States)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Angioplasty; Thrombolysis; Ultrasonics

Indexed keywords

ABCIXIMAB;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT; SIDE EFFECT; STROKE; TREATMENT OUTCOME; ULTRASOUND;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SAPHENOUS VEIN; STENTS; SYNDROME; THROMBOSIS; TREATMENT OUTCOME; ULTRASONIC THERAPY;

EID: 0038751992     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000066693.22220.30     Document Type: Article

References (20)

1. Bourassa MG, Fisher LD, Campeau L, et al. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation. 1985;72(suppl 5):V-71-V-78.
2. Lefkovits J, Holmes DR, Califf RM, et al. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial: Coronary Angioplasty Versus Excisional Atherectomy Trial. Circulation. 1995;92:734-740.
3. Holmes DR Jr., Topol EJ, Califf RM, et al. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions: CAVEAT-II Investigators. Circulation. 1995;91:1966-1974.
4. Moses JW, Moussa I, Popma JJ, et al. Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries: NACI Investigators. New Approaches to Coronary Interventions. Catheter Cardiovasc Interv. 1999;47:149-154.
5. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol. 2001;38:150-154.
6. Mathew V, Clavell AL, Lennon RJ, et al. Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: changes in patient characteristics and outcome during two decades. Am J Med. 2000;108:127-135.
7. Carlino M, De Gregorio J, Di Mario C, et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty: experience with a new temporary occlusion and aspiration system. Circulation. 1999;99:3221-3223.
8. Nakagawa Y, Matsuo S, Kimura T, et al. Thrombectomy with AngioJet catheter in native coronary arteries for patients with acute or recent myocardial infarction. Am J Cardiol. 1999;83:994-999.
9. Mathew V, Grill DE, Scott CG, et al. The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions. J Am Coll Cardiol. 1999;34:1163-1169.
10. Mak KH, Challapalli R, Eisenberg MJ, et al. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts: EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications. Am J Cardiol. 1997;80:985-988.
11. Singh M, Reeder GS, Ohman EM, et al. Does the presence of thrombus seen on a coronary angiogram affect the outcome after percutaneous coronary angioplasty? An Angiographic Trials Pool data experience. J Am Coll Cardiol. 2001;38:624-630.
12. Ellis SG, Guetta V, Miller D, et al. Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb/IIIa era: an analysis of results from 10,907 lesions and proposal for new classification scheme. Circulation. 1999;100:1971-1976.
13. Rosenschein U, Roth A, Rassin T, et al. Analysis of Coronary Ultrasound Thrombolysis Endpoints in acute myocardial infarction (ACUTE trial): results of the feasibility phase. Circulation. 1997;95:1411-1416.
14. Rosenschein U, Gaul G, Erbel R, et al. Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? Circulation. 1999;99:26-29.
15. Singh M, Berger PB, Ting HH, et al. Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience). Am J Cardiol. 2001;88:1091-1096.
16. Berger PB, Bell MR, Grill DE, et al. Influence of procedural success on immediate and long-term clinical outcome of patients undergoing percutaneous revascularization of occluded coronary artery bypass vein grafts. J Am Coll Cardiol. 1996;28:1732-1737.
17. Kahn JK, Rutherford BD, McConahay DR, et al. Initial and long-term outcome of 83 patients after balloon angioplasty of totally occluded bypass grafts. J Am Coll Cardiol. 1994;23:1038-1042.
18. Kuntz RE, Baim DS, Cohen DJ, et al. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS2]). Am J Cardiol. 2002;89:326-330.
19. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002;105:1285-1290.
20. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 1995;332:1553-1559.